RAFAEL
SAN JUAN GARRIDO
Profesor asociado de Ciencias de la Salud
Hospital Clinico Universitario de Valencia
Valencia, EspañaPublications en collaboration avec des chercheurs de Hospital Clinico Universitario de Valencia (15)
2023
-
Comparison of intracellular cytokine staining versus an ELISA-based assay to assess CMV-specific cell-mediated immunity in high-risk kidney transplant recipients
Journal of Medical Virology, Vol. 95, Núm. 4
2022
-
Human pegivirus type 1 infection in kidney transplant recipients: Replication kinetics and clinical correlates
Transplant Infectious Disease, Vol. 24, Núm. 1
-
Impact of polymorphisms in genes orchestrating innate immune responses on replication kinetics of Torque teno virus after kidney transplantation
Frontiers in Genetics, Vol. 13
2021
-
SARS-CoV-2-specific Cell-mediated Immunity in Kidney Transplant Recipients Recovered From COVID-19
Transplantation, Vol. 105, Núm. 6, pp. 1372-1380
-
T cell–mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19
American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2785-2794
2020
-
A New Clinical and Immunovirological Score for Predicting the Risk of Late Severe Infection in Solid Organ Transplant Recipients: The CLIV Score
The Journal of infectious diseases, Vol. 222, Núm. 3, pp. 479-487
2019
-
Monitoring of alphatorquevirus DNA levels for the prediction of immunosuppression-related complications after kidney transplantation
American Journal of Transplantation, Vol. 19, Núm. 4, pp. 1139-1149
-
Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment
Clinical Microbiology and Infection, Vol. 25, Núm. 3, pp. 381.e1-381.e10
2018
-
Dalbavancin in the treatment of different gram-positive infections: a real-life experience
International Journal of Antimicrobial Agents, Vol. 51, Núm. 4, pp. 571-577
2017
-
Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey
Transplant Infectious Disease, Vol. 19, Núm. 6
2016
-
Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations
Transplantation Reviews, Vol. 30, Núm. 3, pp. 119-143
2015
-
Effect of delaying prophylaxis against CMV in D+/R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease
Journal of Infection, Vol. 71, Núm. 5, pp. 561-570
-
Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients
Transplant Infectious Disease, Vol. 17, Núm. 5, pp. 637-646
2013
-
Epstein-barr virus DNAemia is an early surrogate marker of the net state of immunosuppresion in solid organ transplant recipients
Transplantation, Vol. 95, Núm. 5, pp. 688-693
2011
-
GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients Recomendaciones GESITRA-SEIMC/REIPI para el manejo de la infección por citomegalovirus en pacientes trasplantados de órgano sólido
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 10, pp. 735-758